| CBGRX | RBFFX | CBGRX / RBFFX | |
| Total Expense Ratio | 0.43 | 0.28 | 154% |
| Annual Report Gross Expense Ratio | 0.44 | 0.28 | 157% |
| Fund Existence | 7 years | 24 years | - |
| Gain YTD | 0.177 | -0.570 | -31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 250 | 2,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 813M | 101B | 1% |
| Annual Yield % from dividends | 3.82 | 4.44 | 86% |
| Returns for 1 year | 3.77 | 3.57 | 106% |
| Returns for 3 years | 14.17 | 11.98 | 118% |
| Returns for 5 years | 0.90 | -0.58 | -154% |
| Returns for 10 years | N/A | 15.12 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 29.56 | N/A | N/A |
| Fidelity Disruptive Medicine ETF | |||
| MYCF | 25.01 | N/A | N/A |
| State Street® My2026 Corporate Bond ETF | |||
| TPLS | 24.98 | N/A | N/A |
| Thornburg Core Plus Bond ETF | |||
| BGH | 14.14 | -0.06 | -0.42% |
| Barings Global Short Duration High Yield Fund | |||
| EMGF | 69.07 | -2.55 | -3.56% |
| iShares Em Mkts Eq Fac ETF | |||